Synthetic Development of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) as Anti-HIV Drugs: Efavirenz and its Derivatives

Publisher： Bentham Science Publishers

E-ISSN： 1875-5348|21|21|2196-2206

ISSN： 1385-2728

Source： Current Organic Chemistry, Vol.21, Iss.21, 2017-11, pp. : 2196-2206

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Stable Synthetic Bacteriochlorins: Potent Light-Activated Anti-Cancer Drugs

By  

Current Organic Chemistry, Vol. 19, Iss. 10, 2015-05 ,pp. : 948-957

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Targets for the Development of Anti-Trypanosoma Cruzi Drugs: A Brief Review

By  

Mini-Reviews in Organic Chemistry, Vol. 13, Iss. 3, 2016-06 ,pp. : 227-243

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery of a Small Molecule Inhibitor of the Interaction Between HIV-1 Proteins and Cellular Cofactors: A Novel Candidate Anti-HIV-1 Drug

By  

Current Chemical Biology, Vol. 4, Iss. 3, 2010-09 ,pp. : 188-199

Bentham Science Publishers

Access to resources Recommend Favorite

Synthetic Approaches to Various Class of Topoisomerase II Inhibitors

By  

Mini-Reviews in Organic Chemistry, Vol. 14, Iss. 5, 2017-09 ,pp. : 357-374

Bentham Science Publishers

Access to resources Recommend Favorite

Synthetic Routes of Sulfonamide Derivatives: A Brief Review

By  

Mini-Reviews in Organic Chemistry, Vol. 10, Iss. 2, 2013-05 ,pp. : 160-170

Bentham Science Publishers

Access to resources Recommend Favorite